Cite
HARVARD Citation
Hamano, S. et al. (n.d.). Oncolytic reovirus combined with trastuzumab enhances antitumor efficacy through TRAIL signaling in human HER2-positive gastric cancer cells. Cancer letters. 356 (2), pp. 846-854. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hamano, S. et al. (n.d.). Oncolytic reovirus combined with trastuzumab enhances antitumor efficacy through TRAIL signaling in human HER2-positive gastric cancer cells. Cancer letters. 356 (2), pp. 846-854. [Online].